|
|
|
Volumn 34, Issue 5, 1999, Pages 461-462
|
|
New single-bolus thrombolytics ease administration, match t-PA in efficacy
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FIBRINOLYTIC AGENT;
LANOTEPLASE;
NEW DRUG;
TENECTEPLASE;
TISSUE PLASMINOGEN ACTIVATOR;
UNCLASSIFIED DRUG;
ACUTE HEART INFARCTION;
BLOOD TRANSFUSION;
BOLUS INJECTION;
BRAIN HEMORRHAGE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG HALF LIFE;
FIBRINOLYTIC THERAPY;
HUMAN;
MORTALITY;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
STROKE;
|
|
EID: 0033049221
PISSN: 1082801X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|